The other day we heard Sally Davies saying that she wants and expects gene sequences for all cancer patients. (E.g. healthunlocked.com/thyroidu...... and other posts in the past few days.)
Now a paper identifies several genetic components that are at least associated with Hashimoto's and/or Graves and their disease courses.
I'd like to think the simple fact that thyroid patients typically suffer for decades would be a very strong argument in favour of gene sequencing. If knowledge of the genetic make-up of the individual can provide insight into their disease, suggest even marginal improvements in treatment, etc., those pluses are multiplied by so many years... Could we ever see the concept of quality-adjusted life decades being used to justify better healthcare? And how much would they be "worth"?
For any who ask, no, I don't understand genetics any better than you!
Autoimmunity. 2017 Jul 4:1-7. doi: 10.1080/08916934.2017.1344971. [Epub ahead of print]
Association of the polymorphisms in the gene encoding thyroglobulin with the development and prognosis of autoimmune thyroid disease.
Mizuma T1, Watanabe M1, Inoue N1,2, Arakawa Y1, Tomari S1, Hidaka Y2, Iwatani Y1.
Author information
1 a Department of Biomedical Informatics, Division of Health Sciences , Osaka University Graduate School of Medicine , Osaka , Japan.
2 b Laboratory for Clinical Investigation , Osaka University Hospital , Osaka , Japan.
Abstract
Graves' disease (GD) and Hashimoto's disease (HD) are autoimmune thyroid diseases (AITDs), and the prognosis of AITDs is different for each patient. We examined the association of polymorphisms in the Thyroglobulin (TG) gene with the pathogenesis of AITD. We genotyped TG rs180195G/A, rs853326G/A, rs2076740C/T, rs2703013G/T, rs2958692C/T and rs733735A/G polymorphisms in 137 HD patients, 131 GD patients and 89 healthy controls and also examined the levels of TG mRNA expression and serum TG. The TG rs180195 GG genotype was more frequent in HD patients (p = .0277), and the proportion of CD4+ cells with high levels of TG mRNA was greater in individuals with the GG genotype than in A carriers (p = .0107). The TG rs2703013 TT genotype was less frequent in AITD (p = .0186), and serum TG levels were lower in individuals with the TT genotype than in G carriers (p = .0170). In the TG rs2958692 polymorphism, the T allele was more frequent in intractable GD than in GD in remission (p = .0055), and serum titres of anti-thyroglobulin antibody (TgAb) were lower in GD patients with the TT genotype than in C carriers (p = .0151). In the TG rs2076740 polymorphism, serum titres of TgAb were higher in HD patients who were T carriers than in those with the CC genotype (p = .0359). SNPs in the TG gene were associated with the development of HD and GD, the intractability of GD, and the levels of TG mRNA expression, serum TG, and serum TgAb.
KEYWORDS:
Graves’ disease; Hashimoto’s disease; Thyroglobulin; polymorphism; severity
PMID: 28675712
DOI: 10.1080/08916934.2017.1344971